Integrin function and activation of signaling pathways in osteoblastic cells;Integrin funktion und aktivierung von signalkaskaden in osteoblastären zellen

Osteologie

Volumn 10, Issue 2, 2001, Pages 75-85

  Hickok, N J ^a   Noth U ^a   Seghatoleslami, R ^a   Howard, M ^a   Shah, A ^a   Hall, D J ^a   Tuan, R S ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Adhesion; Biomaterial; Integrin; Osteoblast; p125FAK

Indexed keywords

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN 2; CELL SURFACE RECEPTOR; GROWTH FACTOR; INTEGRIN; INTEGRIN RECEPTOR;

BONE MINERALIZATION; CALLUS; CELL ADHESION; CELL FATE; CELL INTERACTION; CELL MATURATION; CELL PROLIFERATION; CELL SURFACE; EXTRACELLULAR MATRIX; FRACTURE; HUMAN; HUMAN CELL; OSTEOBLAST; OSTEOLYSIS; PROTEIN ANALYSIS; PROTEIN MODIFICATION; REVIEW; SIGNAL TRANSDUCTION; SURFACE PROPERTY;

EID: 0034888585     PISSN: 10191291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. The optimum pore size for the fixation of porous-surface metal implants by the ingrowth of bone
2. TGFβ alters growth and differentiation related gene expression in proliferating osteoblasts in vitro, preventing development of the mature bone phenotype
3. Transforming growth factor-β gene family members and bone
4. Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages
5. Determinants of specificity in TGF-beta signal transduction
6. The type II transforming growth factor (TGF)-β receptor-interacting protein TRIP-1 acts as a modulator of the TGF-β response
7. Integrins and signal transduction pathways: The road taken
8. Use of bone morphogenetic protein 2 on ectopic porous coated implants in the rat
9. Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases
10. Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases
11. Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene
12. Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription
13. Cell proliferation of human fibroblasts and osteoblasts in osteogenesis imperfecta: Influence of age
14. The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for Smad3 in TGF-beta-induced transcriptional activation
15. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation
16. Integrin signaling
17. Fibronectin is a survival factor for differentiated osteoblasts
18. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133
19. c-Fos: A key regulator of osteoclast-macrophage lineage determination and bone remodeling
20. Enhanced extracellular matrix production and mineralization by osteoblasts cultured on titanium surfaces in vitro
21. Response of human osteoblasts to implant materials: Integrin-mediated adhesion
22. Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter
23. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta
24. Integrins: Versatility, modulation, and signaling in cell adhesion
25. Specific activation of the p38 mitogen-activated protein kinase signaling pathway and induction of neurite outgrowth in PC12 cells by bone morphogenetic protein-2
26. Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible enhancer
27. The role of BMPs and GDFs in development of region-specific skeletal structures
28. Cbfa1 in bone development
29. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts
30. Collagen and collagenase gene expression in three-dimensional collagen lattices are differentially regulated by alpha 1 beta 1 and alpha 2 beta 1 integrins
31. Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia
32. Activation of protein kinase A is a pivotal step involved in both BMP-2 and cyclic AMP-induced chondrogenesis
33. Smads bind directly to the Jun family of AP-1 transcription factors
34. Production of chemokines, interleukin-8 and monocyte chemoattractant protein-1, during monocyte: Endothelial cell interactions
35. MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling
36. TGF-beta signal transduction
37. The TGF-β family and its composite receptors
38. Inorganic phosphate induces apoptosis of osteoblast-like cells in culture
39. Bone morphogenetic proteins induce cardiomyocyte differentiation through the mitogen-activated protein kinase kinase kinase TAK1 and cardiac transcription factors Csx/Nkx-2.5 and GATA-4
40. Interactions between integrin receptors and fibronectin are required for calvarial osteoblast differentiation in vitro
41. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia
42. Assays for bone resorption and bone formation
43. Integrin-mediated activation of focal adhesion kinase is required for signaling to Jun NH2-terminal kinase and progression through the G1 phase of the cell cycle
44. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development
45. Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix
46. Protein kinase signalling pathways involved in the up-regulation of the rat α1(I) collagen gene by transforming growth factor β1 and bone morphogenetic protein 2 in osteoblastic cells
47. Identification of a transforming growth factor-beta1/bone morphogenetic protein 4 (TGF-beta1/BMP4) response element within the mouse tissue transglutaminase gene promoter
48. Human bone cells in vitro
49. RGD and other recognition sequences for integrins
50. Anchorage dependence, integrins, and apoptosis
51. ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factorbeta signaling
52. Quantitative changes in integrin and focal adhesion signaling regulate myoblast cell cycle withdrawal
53. Mechanism of BMP-2 stimulated adhesion of osteoblastic cells to titanium alloy
54. High-resolution morphometric analysis of human osteoblastic cell adhesion on clinically relevant orthopedic alloys
55. Pyk2 and src-family protein-tyrosine kinases compensate for the loss of FAK in fibronectin-stimulated signaling events but Pyk2 does not fully function to enhance FAK- cell migration
56. Surface composition of orthopaedic implant metals regulates cell attachment, spreading, and cytoskeletal organization of primary human osteoblasts in vitro
57. In vitro analysis of the bone-implant interface
58. Expression of cell cycle regulatory factors in differentiating osteoblasts: Postproliferative up-regulation of cyclins B and E
59. Enhancement of bone ingrowth by transforming growth factor-beta
60. Inhibition of osteoblast-specific transcription factor Cbfa1 by the cAMP pathway in osteoblastic cells: Ubiquitin/proteasome dependent regulation
61. SIP1, a novel zinc finger/homeodomain repressor, interacts with Smad proteins and binds to 5′-CACCT sequences in candidate target genes
62. Smad-dependent transcriptional activation of human type VII collagen gene (COL7A1) promoter by transforming growth factor-β
63. Bone and haematopoietic defects in mice lacking c-fos
64. Biochemical analysis of integrin-mediated Shc signaling
65. Integrins alpha v beta 3 and alpha v beta 5 contribute to cell attachment to vitronectin but differentially distribute on the cell surface
66. Multiple modes of repression by the Smad transcriptional corepressor TGIF
67. CBFA1 mutation analysis and functional correlation with phenotypic variability in cleidocranial dysplasia